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www.sciencemag.org/content/346/6216/1480/suppl/DC1 Materials and Methods Figs. S1 to S16 Tables S1 to S8 Databases S1 to S8 References (28-34) 14 Multivalent molecules with repetitive structures including bacterial capsular polysaccharides and viral capsids elicit antibody responses through B cell receptor (BCR) crosslinking in the absence of T cell help. We report that immunization with these T cell-independent type 2 (TI-2) antigens causes up-regulation of endogenous retrovirus (ERV) RNAs in antigen-specific mouse B cells. These RNAs are detected via a mitochondrial antiviral signaling protein (MAVS)-dependent RNA sensing pathway or reverse-transcribed and detected via the cGAS-cGAMP-STING pathway, triggering a second, sustained wave of signaling that promotes specific immunoglobulin M production. Deficiency of both MAVS and cGAS, or treatment of MAVS-deficient mice with reverse transcriptase inhibitors, dramatically inhibits TI-2 antibody responses. These findings suggest that ERV and two innate sensing pathways that detect them are integral components of the TI-2 B cell signaling apparatus.
S pecific antibody production is a hallmark of the B cell response to antigens. T celldependent (TD) antibody responses typically elicited by protein antigens require follicular helper T cells for full B cell activation, proliferation, and antibody production. In contrast, T cell-independent (TI) antigens stimulate antibody production in the absence of major histocompatibility complex (MHC) class II-restricted T cell help. TI antigens include the TI type 1 (TI-1) antigens, which engage Toll-like receptors (TLRs) in addition to the B cell receptor (BCR), and TI type 2 (TI-2) antigens, which engage the BCR in a manner that induces extensive crosslinking, leading to BCR activation and immunoglobulin M (IgM) production. TI-2 antigens are large multivalent molecules with highly repetitive structures, such as bacterial capsular polysaccharides and viral capsids (1).
B cell-intrinsic cytosolic DNA and RNA sensing in the TI-2 antibody response
We tested the requirement for innate immune sensing pathways in the antibody response to the model TI-2 antigen 4-hydroxy-3-nitrophenylacetylFicoll (NP-Ficoll) by monitoring anti-NP IgM in the serum of mice after immunization (2) . C57BL/6J mice mounted a robust NP-specific IgM response by day 4.5 after immunization, which peaked around day 14.5 after immunization (Fig. 1A and  fig. S1 ). Similarly, mice that could not signal via  NLRP3, TLR3, TLR7, TLR9, TLR2, TLR4, CD36,  MyD88, TICAM1, or IRAK4, all nucleic acid-sensing  TLRs (Unc93b1   3d/3d ), or all TLRs (Ticam1 Lps2/Lps2 ; Irak4 otiose/otiose ) produced normal levels of NPspecific IgM on day 4.5 after immunization (Fig.  1A) . In contrast, Tmem173 gt/gt mice and Mb21d1 −/− mice, deficient in the cytosolic DNA-sensing pathway components stimulator of interferon gene (STING) and cGMP-AMP synthase (cGAS), respectively, exhibited suboptimal IgM responses to NP-Ficoll on day 4.5 and for up to 30 days after immunization ( Fig. 1A and fig. S1 ). Mice lacking mitochondrial antiviral signaling protein (MAVS), an adaptor for the cytoplasmic RNA-sensing RIG-I-like helicases, also produced diminished amounts of NP-specific IgM (Fig. 1A and fig. S1 ). Antibody responses to the TI-1 antigen NP-LPS (LPS, lipopolysaccharide) (Fig. 1B) , and the TD antigen b-galactosidase (b-gal) encoded by a nonreplicating recombinant Semliki Forest virus (rSFV) vector (3) (Fig. 1C) , were normal in STING-, cGAS-, and MAVS-deficient mice. We evaluated marginal zone (MZ) and B-1 B cell populations in STING-, cGAS-, and MAVSdeficient mice and found no deficiencies in frequencies or numbers ( fig. S2 and supplementary text), except in the NP-specific populations after NP-Ficoll immunization ( fig. S3 ). Also, NP-Ficoll capture by MZ B cells and MZ macrophages was normal in the mutant mice ( fig. S4 ).
We performed adoptive transfer of C57BL/6J, STING-, cGAS-, or MAVS-deficient splenic and peritoneal B cells into Rag2 −/− mice and immunized recipient mice with NP-Ficoll one day after transfer. Despite similar reconstitution of the B cell compartment by donor cells ( fig. S5 ), mice that received STING-, cGAS-, or MAVS-deficient B cells produced diminished amounts of NPspecific IgM on day 4.5 after immunization, as compared to mice that received C57BL/6J B cells (Fig. 1D ). These data demonstrate that B cellintrinsic MAVS and cGAS-STING signaling are necessary for antibody responses to TI-2 immunization.
B cell activation by cGAMP
The DNA sensor cGAS binds to cytosolic DNA and catalyzes the synthesis of cGMP-AMP (cGAMP), a cyclic dinucleotide that binds and activates STING, leading to type I interferon production (4). We found that the presence of DNA in the cytoplasm was sufficient to activate C57BL/6J, but not STING-deficient splenic B cells in vitro ( Fig. 2A, fig. S6 , and supplementary text). After NP-Ficoll immunization of C57BL/6J mice, cGAMP levels were elevated for at least 10 days in NPspecific B cells relative to levels in non-NP-specific or naïve B cells (Fig. 2 , B and C). In vitro cGAMP treatment activated B cells from C57BL/6J but not STING-deficient mice (Fig. 2 , D and E), whereas in vivo cGAMP treatment partially rescued NPspecific IgM levels in the serum of cGAS-deficient mice immunized with NP-Ficoll together with cGAMP ( Fig. 2F) . Thus, cytoplasmic DNA and cGAMP are sufficient to activate B cells in a STING-dependent manner. Human B cells were also activated by cGAMP treatment in vitro (Fig. 2G ). These findings implicate cytosolic DNA sensed by the cGAS-STING pathway in B cell activation by TI-2 antigens. The impaired antibody response of MAVS-deficient mice immunized with NP-Ficoll (Fig. 1A) suggested that cytosolic RNA may also activate B cells.
ERV transcription and reverse transcription in TI-2 antigen-specific B cells
No exogenous nucleic acid species are known to be introduced into B cells upon BCR engagement by TI-2 antigens, suggesting that endogenous nucleic acids are responsible for activation of the cGAS-STING and MAVS pathways. We hypothesized that RNA and reverse-transcribed DNA derived from endogenous retroviruses (ERVs) or retrotransposons might gain access to the B cell cytoplasm upon BCR signaling. The retroviral life cycle entails the transient localization of RNA and, via reverse transcription, DNA within the cytoplasm (5). Both cGAS-STING (6) and RIG-I-MAVS pathways (7) have been implicated in the sensing of HIV-1 and other retroviruses. We therefore investigated whether ERVs could be induced by TI-2 immunization.
We measured transcript levels of individual ERVs in B cells after immunization of C57BL/6J mice with NP-Ficoll; DNA contamination of the RNA samples was excluded ( fig. S7A ). Compared to non-NP-specific B cells on day 4.5 after immunization, NP-specific B cells displayed increased expression of multiple ERV mRNAs (Fig. 3A) . We found that total RNA isolated from NP-specific B cells was significantly more potent than total RNA from non-NP-specific B cells in activating cytokine and chemokine gene expression in bone marrow-derived macrophages (BMDMs) ( fig. S7 , B to D). Gene expression induced by NP-specific B cell total RNA was partially dependent on MAVS (fig. S7C); ribonuclease treatment abrogated the effect ( fig. S7D ). To test the idea that a MAVSdependent RNA sensing pathway could be activated by ERV RNAs in NP-specific B cells, we used RIG-I immunoprecipitation followed by reverse transcription polymerase chain reaction (RT-PCR) analysis and found that all tested ERV mRNA sequences bound to RIG-I molecules in NP-specific B cells from immunized mice; greater amounts of ERV mRNA were immunoprecipitated with RIG-I from NP-specific B cells than from non-NP-specific B cells (Fig. 3B) . We also verified the selective binding of RIG-I to ERV mRNA versus cellular mRNA ( fig. S7E ).
Reverse transcription of retroviral RNA occurs in the cytoplasm and produces cDNA that can be detected by cGAS (6) . Measurement of cytoplasmic ERV DNA ( fig. S8A ) revealed elevated levels in NP-specific B cells as compared to non-NP-specific B cells from immunized C57BL/6J mice (Fig. 3C ). Consistent with this finding, the activity of reverse transcriptase (RT) was upregulated in NP-specific relative to non-NP-specific or naïve B cells (Fig. 3D) . We used inhibitors of RT to determine whether reverse transcription is necessary for B cell activation and antibody production in mice immunized with NP-Ficoll. B cells were cultured in vitro and treated with NP-Ficoll and the RT inhibitors azidothymidine (AZT), nevirapine (NVP), and didanosine (ddI). RT inhibition significantly reduced CD86 and GL7 expression in C57BL/6J and MAVS-deficient NP-specific B cells relative to NP-specific B cells without RT inhibition (Fig. 3, E and F) . In vivo, C57BL/6J mice pretreated with AZT and NVP followed by immunization with NPFicoll showed varying but significant reductions in ERV DNA levels in the cytoplasm of NP-specific B cells compared to immunized mice treated with vehicle ( fig. S8B) , which is consistent with the known differential susceptibility of RT enzymes to distinct RT inhibitors (8, 9) . C57BL/6J and MAVS-deficient mice treated with RT inhibitors exhibited impaired NP-specific IgM production relative to immunized vehicle-treated mice (Fig.  3G) . However, no additive impairment of activation marker expression on NP-specific B cells in vitro, or of NP-specific IgM production in vivo, resulted from RT inhibition in STING-deficient B cells or mice (Fig. 3 , E to G). Consistent with these findings, double knockout of MAVS and cGAS reduced NP-specific IgM production to nearly undetectable levels in the serum of immunized mice (Fig. 3H) . We also immunized double knockout mice deficient in MAVS and STING and noted that, although reduced as compared to mice lacking either protein alone, residual NP-specific IgM production still occurred, suggesting that cGAS may have functions independent of cGAMP production or that alternate cGAMP receptor(s) remain to be identified ( fig.  S9 ). These data suggest that TI-2 immunization activates transcription and reverse transcription to produce ERV mRNAs and cDNAs. These nucleic acids probably then engage the RIG-I-MAVS and cGAS-STING pathways, leading to signaling necessary for B cell activation and antigen-specific antibody production. We note that the potential involvement in TI-2 antibody responses of LINE-1 elements, which are also susceptible to RT inhibition, remains to be tested.
NF-kB is required for ERV induction and is activated by BCR and MAVS signaling
TI-2 antigens engage the BCR and trigger signaling events, including the activation of Src kinases, the Tec family kinase Btk, and subsequently NF-kB (10), which is known to activate the transcription of exogenous retroviruses in other cells (11, 12) . Because mutations affecting the BCR reduce or eliminate B cells, we investigated the involvement of BCR signaling in the induction of ERVs by measuring ERV mRNA levels in response to BCR engagement by antiIgM in vitro. Anti-IgM treatment increased activation marker expression (Fig. 4A) , caused strong up-regulation of multiple ERV mRNAs (Fig. 4B) , and elevated cGAMP (Fig. 4C ) in C57BL/6J B cells. Human B cells also up-regulated ERV mRNAs upon treatment with anti-IgM in vitro (Fig. 4D) . These data indicate that BCR ligation is sufficient to induce ERV transcription in mouse and human B cells, as well as activation of cGAS in mouse B cells. MAVS-and cGAS-deficient B cells failed to fully up-regulate activation markers in response to anti-IgM (Fig. 4A) ; these findings are consistent with MAVS and cGAS activation induced by BCR signaling. Downstream from the BCR, Btk activation is a defining feature of the signaling induced by TI-2 antigens (1). Btk-deficient xid mice failed to produce NP-specific IgM on day 4.5 after immunization with NP-Ficoll (Fig. 4E) , which is consistent with previously reported data (13) . NP-specific B cells from immunized xid mice expressed similar levels of ERV mRNAs as non-P-specific B cells from either xid mice or from control mice (Fig. 4F) . In human B cells in vitro, the BTK inhibitor Ibrutinib blocked both the expression of activation markers (Fig. 4G ) and the elevation of ERV transcription induced by anti-IgM (Fig. 4D) . These findings demonstrate that Btk is necessary for the induction of ERV mRNAs in mouse B cells by TI-2 immunization, and in human B cells by BCR ligation.
Data from several experiments supported a requirement for NF-kB in the antibody response to TI-2 immunization, and specifically in the induction of ERV mRNAs. First, NF-kB-dependent cytokines were up-regulated in NP-specific B cells from C57BL/6J mice immunized with NP-Ficoll, whereas non-NP-specific B cells showed cytokine production similar to that of naïve B cells (Fig. 5A) . Second, mutation of NEMO (Ikbkg panR2 ), a component of the IKK complex required for NF-kB activation, abrogated the NP-specific IgM response of C57BL/6J mice to NP-Ficoll immunization (Fig. 1A) . Third, NP-specific B cells from NEMO-deficient mice expressed ERV mRNA levels similar to those of non-NP-specific B cells (Fig. 5B) . Signaling from the BCR, RIG-I-MAVS, and cGAS-STING pathways all activate NF-kB (10, 14, 15) , and we sought to identify which pathway(s) drive NF-kB activation needed for the TI-2 antibody response. We found that anti-IgM failed to induce ERV mRNAs in NEMO-deficient B cells in vitro (Fig. 4B) , suggesting that BCR signaling induces ERV mRNAs via NF-kB. As we have demonstrated, ERV transcripts trigger a second, sustained wave of signaling via the RIG-I-MAVS and cGAS-cGAMP-STING pathways that may also require NF-kB to activate B cells and stimulate antibody production. We evaluated NF-kB activation by measuring levels of phosphorylated p65 and p105. In response to anti-IgM, C57BL/6J, MAVS-, and cGAS-deficient B cells displayed elevated levels of phospho-p65 and phospho-p105 as compared to vehicle-treated cells; however, MAVS-deficient cells showed a diminished level of NF-kB activation relative to C57BL/6J cells (Fig. 5C ). Analysis of p65 nuclear translocation corroborated these findings (Fig. 5D) . Similarly, NP-specific B cells from immunized C57BL/6J, MAVS-, and cGAS-deficient mice displayed elevated phospho-p105 relative to non-NP-specific B cells; MAVS deficiency prevented NF-kB activation to the extent observed in C57BL/6J NPspecific B cells (Fig. 5E ). These data suggest that MAVS signaling but not cGAS-STING signaling activates NF-kB in response to ERV nucleic acids induced by BCR engagement. The finding that NP-specific B cell RNA from immunized mice transcriptionally activated NF-kB target genes, including those encoding TNFa, IL-6, MCP-1, and COX-2, in a MAVS-dependent manner (fig. S7, C and D) further supports this conclusion.
cGAS-STING and MAVS signaling in antibody responses to Streptococcus pneumoniae capsular polysaccharides
We immunized cGAS-, STING-, MAVS-, or cGAS/ MAVS-deficient mice with Streptococcus pneumoniae capsular polysaccharides (PSs) 1 and 3 or with the commercial vaccine Pneumovax 23 (PPV-23), containing 23 S. pneumoniae polysaccharide antigens. By day 4.5 after immunization, C57BL/6J mice mounted a PS1-and PS3-specific IgM response, which was significantly diminished in cGAS-or MAVS-deficient mice (Fig. 6A ). Mice lacking both cGAS and MAVS displayed a further reduction in PS1-and PS-3-specific IgM to nearly undetectable levels (Fig. 6A) . Similarly, upon immunization with Pneumovax 23, cGASor STING-deficient mice produced diminished amounts of PPV-23-specific IgM and IgG as compared to C57BL/6J mice (Fig. 6 , B and C). Thus, the requirement for cGAS-STING and RIG-I-MAVS pathways, likely due to their detection of ERV nucleic acids, extends to antibody responses against TI-2 antigens of a clinically important human pathogen.
Discussion
With respect to ERVs, we hypothesize that the following events occur in B cells after TI-2 immunization: (i) ERV proviruses are transcribed, and the resulting unspliced and spliced RNAs are transported to the cytoplasm; (ii) ERV mRNAs are translated to produce RT(s) (Fig. 3D ), Env glycoprotein(s) ( fig. S10A ), and possibly other ERV proteins; (iii) ERV mRNAs are reverse-transcribed to produce cDNAs by one or more of the RT species produced in step (ii); and (iv) ERV mRNAs and cDNAs present in the cytoplasm activate RIG-I and cGAS, respectively (fig. S11). Although retroviruses including HIV-1 and MLV typically proteolytically process RT from the Gag-Pol polyprotein during or after virus budding, RT has also been reported to be active in the precursor form (16, 17) ; similar ERV-derived precursors may provide the RT activity we measured in NP-specific B cell lysates. Overall, our data support the hypothesis that ERV nucleic acids induced in the TI-2 antigen-activated B cell are sufficient to trigger cytosolic innate sensors, leading to subsequent antibody production by the same cell ( fig. S11 ). However, despite multiple experiments supporting the involvement of ERV nucleic acids, it remains possible that their presence and activity are incidental to other component(s) essential for the activation of MAVS, cGAS, STING, and ultimately TI-2 antibody responses. Determining whether ERV nucleic acids represent a necessary component of the antibody response will require comprehensive inactivation of ERV sequences across the genome. The appropriation of ERV genes for host immunity has often been observed in defense against exogenous retroviruses, as exemplified by Fv1 (18) and Fv4 (19) . Whereas the host recruits a single ERV-derived gene to counteract one particular step in the life cycle of an exogenous retrovirus, however, it activates a wide range of ERVs in antigen-specific B cells that then serve to trigger intracellular nucleic acid sensors necessary for the TI-2 antibody response. The fate of these ERV nucleic acids remains unknown. We found in NP-specific B cells from immunized mice that the expression of endogenous murine leukemia virus-specific Env glycoprotein was enhanced ( fig. S10A ), as was RT activity detected in the supernatants ( fig. S10B ). Why ERV proteins are produced and how they might come to exist outside the cell during the TI-2 antibody response are open questions.
Recent reports suggest that aberrant cellular accumulation of endogenous retroelement cDNA and its recognition by cytosolic sensors lead to autoimmune disease in mice (20, 21) . An association of human autoimmune diseases with ERVs has also been postulated (22) . Such diseases may be hypothesized to result from dysregulation of adaptive rather than strictly innate immune activation, in that retroviruses, MAVS, cGAS, and STING serve as components of the normal TI-2 B cell signaling apparatus. 
